Enago Life Sciences
Enago Life Sciences, the medical communications division of Crimson Interactive, provides medical writing, publication planning, medical affairs, and localization across 200+ languages, plus AI writing and reading tools, to biopharma, medical device, and academic clients in 125+ countries.
- Company typePrivate
- Founded2005
- HeadquartersNewark, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Enago Life Sciences does
Enago Life Sciences is the medical communications and language solutions division of Crimson Interactive, a multinational corporation founded in 2005 by Sharad Mittal and headquartered in Newark, New Jersey, with operating entity Crimson Interactive Pvt. Ltd. governed under Indian law. The company delivers a portfolio of professional services organized into four pillars: Scientific and Medical Communications (publication planning, medical affairs consulting, medical writing, medical education, medical information, literature search, graphic design, HEOR/RWE); Localization Solutions (clinical trial translation, regulatory submissions, medical device localization, linguistic validation) supporting 200+ languages; AI Solutions (Trinka AI writing assistant, Enago Read reading assistant, Enago Reports report generator, Enago Labs innovation unit); and Marketing Solutions (medical SEO, PPC, website design, content and social media marketing).
Underlying technology combines proprietary AI tools — including an AI-powered writing assistant built on natural language processing and generative AI for Plain Language Summary drafting — with a 3,000+ person workforce including 70+ dedicated AI/tech professionals. The company operates 10+ offices globally (US, UK, South Korea, China, Japan, Turkey, Colombia, India, Taiwan) and serves clients in 125+ countries, with India functioning as the principal engineering and operational hub. Leadership includes senior medical communications veterans with prior roles at GSK, Sanofi Pasteur, Novartis, Takeda Vaccines, IOP Publishing, and RCNi.
The business model is primarily sales-led professional services delivered through direct enterprise engagement and consultation-driven inside sales, supplemented by subscription-based AI tools. Pricing is quote-based with no publicly disclosed tiers. Customer segments include biopharmaceutical companies (primary), life sciences and healthcare organizations (primary), medical device manufacturers, healthcare professionals, and academic researchers. The company claims 2 million+ authors served cumulatively since 2005 and holds four ISO certifications (ISO 13485:2016, ISO 9001:2015, ISO/IEC 27001:2022, ISO 17100:2015) supporting enterprise pharma procurement.
Enago Life Sciences firmographics
Firmographics- Name
- Enago Life Sciences
- Legal name
- Crimson Interactive Pvt. Ltd.
- Website
- https://lifesciences.enago.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Enago Life Sciences, the medical communications division of Crimson Interactive, provides medical writing, publication planning, medical affairs, and localization across 200+ languages, plus AI writing and reading tools, to biopharma, medical device, and academic clients in 125+ countries.
- Ownership category
- akta.pro rank
Enago Life Sciences industry classification
Industry- Product category
- Medical Communications Services
- NAICS
- Other Scientific and Technical Consulting Services (54169), Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
Keywords
Where Enago Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Newark
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
Enago Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Medical Communications Services: Professional services including publication planning, medical affairs consulting, medical writing, medical education, medical information, literature search, graphic design, and HEOR/RWE services for biopharma and healthcare companies
- Localization and Translation Services: Clinical trial translation, regulatory submissions translations, medical device localization, and linguistic validation services supporting product globalization across 200+ languages
- AI Solutions: AI-powered writing, reading, and reporting tools for medical communications
- Marketing Solutions: Medical SEO, pay-per-click advertising, website design, content marketing, and social media marketing services
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Enago Life Sciences product offering
Product offeringCore offering
Enago Life Sciences provides medical communications, life science localization, and AI-enabled language solutions for biopharma, healthcare, medical device, and academic clients. Core services include publication planning, medical writing, medical affairs, medical education, HEOR/RWE dissemination, clinical trial and regulatory translation, and linguistic validation. AI solutions (Trinka AI, Enago Read, Enago Reports) augment the service portfolio with writing, reading, and reporting assistants built for medical and scientific content.
Product overview
Enago Life Sciences is a comprehensive medical communications and language solutions provider offering a portfolio of 21 distinct services and AI products. The core offering includes Medical Communications services (Publication Planning, Medical Affairs Consulting, Medical Writing, Medical Education, Medical Information, Literature Search, Graphic Design, and HEOR/RWE), complemented by Localization Solutions (Clinical Trial Translation, Regulatory Submissions Translations, Medical and In-Vitro Device Services, Linguistic Validation) supporting over 200 languages. AI Solutions include Trinka AI (writing assistant), Enago Read (reading assistant), Enago Reports (report generation), and Enago Labs (Medical Affairs innovation). Marketing Solutions cover Medical SEO, PPC, Website Design, Content Marketing, and Social Media Marketing. Founded in 2005 and serving 2 million+ authors across 125+ countries, the company employs 3000+ professionals with 70+ dedicated AI/tech professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Enago: Core research communication services including English language editing, publication support, and AI-enabled services for researchers and academics.
- Ulatus
- Voxtab
- Enago Academy
- Trinka AI
- Enago Read
- Enago Reports
Products and services
- Publication Planning Develops strategic plans for successful publication, leveraging extensive experience with leading global publishers. For biopharma and healthcare clients needing structured publication roadmaps.
- Medical Affairs Consulting Strategic guidance ensuring compliance and scientific accuracy, providing insights to enhance medical initiatives in the dynamic healthcare landscape. For biopharma medical affairs teams.
- Medical Writing Transforms intricate data into clear narratives and creates medical content that informs, engages, and advances stakeholder understanding. For biopharma, healthcare, and medical device companies.
- Medical Education Creates meaningful and custom texts with appealing visuals that convey audience-specific messages for education objectives. For healthcare and life sciences training teams.
- Medical Information Provides essential support to healthcare professionals by delivering accurate, well-structured, and compliant content. For healthcare professionals and medical information call center teams.
- Literature Search Works with top medical databases to provide relevant, updated, and accurate literature to boost publication success. For researchers and medical affairs teams.
- Graphic Design Merges innovation with healthcare to create captivating digital experiences that amplify brand and connect with diverse audiences. For healthcare marketers and medical communications teams.
- HEOR/RWE Disseminates Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) value through expert publication planning. For biopharma market access and HEOR teams.
- Clinical Trial Translation Translates clinical trial documents with precision and high ethical standards throughout the product lifecycle. For clinical operations and biopharma sponsors running multi-region trials.
- Regulatory Submissions Translations Helps achieve globalization goals with regulatory compliant translations for submissions across multiple jurisdictions. For biopharma, medical device, and IVD regulatory affairs teams.
- Medical and In-Vitro Device Localization Services Improves accessibility of medical devices in new markets through localization, including in-vitro diagnostics. For medical device manufacturers entering global markets.
- Linguistic Validation Ensures accuracy and cultural relevance of medical translations through rigorous validation processes (ISO 17100:2015 certified). For clinical outcome assessment (COA) and patient-reported outcome teams.
- Medical SEO Medical SEO experts optimize on-page and off-page content for greater visibility in search engines. For healthcare marketers and biopharma brand teams.
- Pay Per Click (PPC) Uses data and expert copywriting to drive high-conversion Return on Advertising Spend (ROAS). For healthcare marketers and biopharma brand teams.
- Website Design Builds intuitive, functional, scalable websites that engage and convert visitors. For healthcare and biopharma marketing teams.
- Content Marketing Crafts brand-aligned content delivering accurate information that audiences value. For healthcare and biopharma content marketing teams.
- Social Media Marketing Crafts compelling narratives and implements strategies across social media platforms for healthcare audiences. For healthcare and biopharma marketing teams.
- Trinka AI AI-powered writing assistant designed for manuscript improvement and academic/scientific writing support. For medical writers, researchers, and scientific authors.
- Enago Read AI-powered reading assistant for enhanced document comprehension and analysis of scientific content. For researchers, reviewers, and medical communications teams.
- Enago Reports AI-powered report generation tool for medical communications, including Plain Language Summary drafting with correct reading level while maintaining scientific accuracy. For medical writers and communications teams.
- Enago Labs Innovation lab building AI-driven solutions for Medical Affairs, focused on advancing innovation in AI-driven medical communications. For biopharma Medical Affairs teams.
Quantifiable outcome
- 2 million+ authors served since founding in 2005
- +3 more outcomes
Companies that use Enago Life Sciences
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
Enago Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Enago Life Sciences partnerships and signals
Strategic signalScale indicators7 records
Expansion highlights5 records
Enago Life Sciences competitors and assessment
Company assessmentDirect peers
- Cactus Communications: India-headquartered scientific communications and language solutions platform (Editage, Cactus Life Sciences) serving researchers, publishers, and pharma. Closest head-to-head competitor with comparable AI writing tools, medical writing, and publication planning offerings.
- Oxford PharmaGenesis: Independent healthscience communications agency specializing in publication planning, medical writing, and medical affairs for pharma clients. Direct competitor in medical communications services with overlapping scientific leadership talent.
- AMICULUM: Global medical communications agency providing scientific content, medical writing, and consultancy to pharma. Comparable in services mix and client base (biopharma) to Enago Life Sciences' med comms practice.
- Fishawack Health: PE-backed global medical communications platform offering publication planning, medical affairs, and creative services to pharma. Competes directly for biopharma enterprise engagements and is consolidated through roll-ups Enago may face in enterprise RFPs.
- RWS Group (Life Sciences division): Specialized localization and translation services for life sciences including clinical trial and regulatory submission translations. Closely comparable to Enago's Ulatus division in life science language services.
- Lionbridge Life Sciences: Global localization provider with a dedicated life sciences practice covering clinical trial, regulatory, and medical device translation. Directly comparable in translation/localization capabilities and pharma client base.
Broad incumbents
- Syneos Health Communications: Large CRO with a dedicated communications arm providing medical affairs, publication planning, and patient engagement. Wider portfolio than Enago, but directly competes for biopharma medical communications work.
- IQVIA: Global CRO and life sciences services giant with substantial medical communications and real-world evidence capabilities. Competes indirectly through scale, integrated offerings, and enterprise pharma relationships.
- Parexel: Large global CRO offering medical communications, regulatory, and clinical development services. Overlaps with Enago in regulatory submission translations and clinical trial documentation services.
Emerging players
- InScience Communications: Medical communications agency offering publication planning, medical writing, and scientific services to pharma and biotech. Smaller scale than Enago but a relevant emerging competitor in specialty therapeutic communications.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Enago Life Sciences social profiles
Digital presenceEnago Life Sciences compliance and trust
Trust signalCompliance5 records
Enago Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Enago Life Sciences leadership team
Management profileNumber of profiles
Profiles13 records
Enago Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Enago Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Enago Life Sciences
What does Enago Life Sciences do?
Enago Life Sciences provides medical communications, life science localization, and AI-enabled language solutions for biopharma, healthcare, medical device, and academic clients. Core services include publication planning, medical writing, medical affairs, medical education, HEOR/RWE dissemination, clinical trial and regulatory translation, and linguistic validation. AI solutions (Trinka AI, Enago Read, Enago Reports) augment the service portfolio with writing, reading, and reporting assistants built for medical and scientific content.
Is Enago Life Sciences a public or private company?
Enago Life Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Enago Life Sciences founded?
Enago Life Sciences was founded in 2005. It employs 51 to 100 people.
Where is Enago Life Sciences based?
Enago Life Sciences is headquartered in Newark, United States, in the North America region.
How does Enago Life Sciences make money?
Four revenue lines are on record. Medical Communications Services are the primary driver. The others are localization and Translation Services, AI Solutions and marketing Solutions.
Who are Enago Life Sciences's main competitors?
Direct peers on record are Cactus Communications, Oxford PharmaGenesis, AMICULUM, Fishawack Health, RWS Group (Life Sciences division) and Lionbridge Life Sciences. Broad incumbents are Syneos Health Communications, IQVIA and Parexel. InScience Communications is listed as an emerging player.
Does Enago Life Sciences have an API?
No public API is recorded for Enago Life Sciences.
What industry is Enago Life Sciences in?
Enago Life Sciences's product category is Medical Communications Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS). Its NAICS code is 54169 and its SIC code is 7372.